98 related articles for article (PubMed ID: 18768567)
1. Commentary on drug-eluting stents: NICE technology appraisal guidance.
Richardson J; Stevens A; Barnett D; Longson C
Heart; 2008 Dec; 94(12):1650-2. PubMed ID: 18768567
[No Abstract] [Full Text] [Related]
2. Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance.
Messori A; Trippoli S
Heart; 2009 May; 95(10):847. PubMed ID: 19401286
[No Abstract] [Full Text] [Related]
3. NICE guidelines for the use of drug-eluting stents: how do we establish worth?
de Belder MA;
Heart; 2008 Dec; 94(12):1646-8. PubMed ID: 18728067
[No Abstract] [Full Text] [Related]
4. Commentary on drug-eluting stents: to use or not to use--that is the question!
Pfisterer ME
Heart; 2008 Dec; 94(12):1648-50. PubMed ID: 18782796
[No Abstract] [Full Text] [Related]
5. NICE, drug-eluting stents and the limits of trial data.
Mohindra R
Heart; 2009 Mar; 95(6):505-6; author reply 506. PubMed ID: 19252009
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stents: costs versus clinical benefit.
O'Neill WW; Leon MB
Circulation; 2003 Jun; 107(24):3008-11. PubMed ID: 12821587
[No Abstract] [Full Text] [Related]
8. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents: cost versus clinical benefit.
Lemos PA; Serruys PW; Sousa JE
Circulation; 2003 Jun; 107(24):3003-7. PubMed ID: 12821586
[No Abstract] [Full Text] [Related]
11. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevaliers B; DiMario C; Fajadeto J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Berenger M; Boam A; Calle JP; Campo G; Carlier S; de Schepper J; Di Bisceglie G; Dobbels H; Farb A; Ghislain JC; Hellbardt S; ten Hoedt R; Isaia C; de Jong P; Lekehal M; LeNarz L; Mhullain FN; Nagai H; Patteet A; Paunovic D; Potgieter A; Purdy I; Raveau-Landon C; Ternstrom S; Van Wuytswinkel J; Waliszewski M;
EuroIntervention; 2009 Jan; 4(4):427-36. PubMed ID: 19284063
[No Abstract] [Full Text] [Related]
12. [Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].
Silber S; Borggrefe M; Böhm M; Hoffmeister HM; Dietz R; Ertl G; Heusch G
Clin Res Cardiol; 2008 Aug; 97(8):548-63. PubMed ID: 18726643
[No Abstract] [Full Text] [Related]
13. Outcome observations with drug-eluting stents.
Steffenino G; Olivari Z
J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):110-2. PubMed ID: 18192800
[No Abstract] [Full Text] [Related]
14. A critical appraisal of the safety and efficacy of drug-eluting stents.
Maluenda G; Lemesle G; Waksman R
Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
[TBL] [Abstract][Full Text] [Related]
15. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery restenosis: a paradigm of current treatment approaches.
Kiernan TJ; Kiernan GD; Yan BD
Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
[TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stents: a comprehensive appraisal.
Butt M; Connolly D; Lip GY
Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
[TBL] [Abstract][Full Text] [Related]
18. The high cost of nonadherence after percutaneous coronary intervention--can health care reform solve this problem?
Mukherjee D
Am Heart J; 2009 Oct; 158(4):506-8. PubMed ID: 19781406
[No Abstract] [Full Text] [Related]
19. Drug-eluting stents are safe.
Garg S; Serruys P
Clin Pharmacol Ther; 2009 Aug; 86(2):130-2. PubMed ID: 19621006
[No Abstract] [Full Text] [Related]
20. Late in-stent restenosis in a patient with drug-eluting stent.
Sultan FA; Kazmi K; Dhakam S; Quraishi AU
J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]